Bringing the fundamentals into focus…
Back to C4 Therapeutics, Inc.
How C4 Therapeutics, Inc. stacks up
CCCC · against 407 other Healthcare companies of similar size
Overall
30/ 100
Near the bottom of its peers.
Ranked #326 of 408 · scores higher than 19% of peers
Bars: peers in each 10-point band of the overall score73 peers with an overall score of 30–39, including CCCC · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around CCCC| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 3 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 4 | 2.9B HKD (≈$365M) | 84 | 99 | 63 | 86 | 0 / 2 | |
| 5 | 433M USD | 81 | 96 | 99 | 99 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score